CrushSCI.com
134.1平均天数
124中位天数
11最短天数
350最长天数
1532025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

64 天

PPP1R14B Promotes Lung Adenocarcinoma Tumorigenesis and Paclitaxel Resistance by Increasing ARPC1A Expression

作者
Yanna Yang; Wenjie You; Xin Wang; Bin Shang; Shujuan Jiang展开收起
作者单位
1. Department of Pulmonary and Critical Care Medicine, Jinan Central Hospital Shandong University Jinan Shandong China; 2. Department of Pulmonary and Critical Care Medicine Central Hospital Affiliated to Shandong First Medical University Jinan Shandong China; 3. Department of Pulmonary and Critical Care Medicine Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China; 4. Department of Thoracic Surgery Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China; 5. Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Shandong University Jinan Shandong China展开收起
PDF源文件 DOI 网页
223 天

DNMT3a Regulates the Proliferation and Apoptosis of Hepatocellular Carcinoma Cells Through RYBP Methylation

作者
Weijun Zhang; Ruixia Wang展开收起
作者单位
1. Laboratory Medicine Department Lanzhou University Second Hospital Lanzhou Gansu China; 2. Second Digestive Department Lanzhou University Second Hospital Lanzhou Gansu China展开收起
PDF源文件 DOI 网页
126 天

Integration of scRNA‐Seq and scATAC‐Seq Revealed the Role of lncRNA RP11‐661C8.2 by Promoting EMT in Clear Cell Renal Cell Carcinoma

作者
Jizhen Cen; Xuefang Liang; Zheng Wen; Shengzhu Huang; Jiaping Li; Haibiao Yan; Kaiqiang Tang; Guifen Zhou; Ning Liang; Qi Zheng; Cheng Su; Zengnan Mo; Zhenyuan Yu展开收起
作者单位
1. Department of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University Guangxi Medical University Nanning China; 2. Center for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine Guangxi Medical University Nanning China; 3. School of Basic Medical Sciences Guangxi Medical University Nanning China; 4. Guangxi Key Laboratory of Precision Medicine in Cardio‐Cerebrovascular Diseases Control and Prevention, First Affiliated Hospital of Guangxi Medical University Guangxi Medical University Nanning China; 5. Department of Urology, The First Affiliated Hospital of Guangxi Medical University Guangxi Medical University Nanning China展开收起
PDF源文件 DOI 网页
98 天

CNOT4 Suppresses Bladder Cancer Progression by Promoting Ubiquitination‐Mediated Degradation of EIF2AK2 and Inhibiting Autophagy

作者
Zechun Peng; Ruipeng Jia; Tiemin Zhang; Jie Yang展开收起
作者单位
1. Department of Urology, Nanjing First Hospital Nanjing Medical University Nanjing Jiangsu Province China; 2. Department of Urology II The Second Affiliated Hospital of Hainan Medical University Haikou Hainan Province China; 3. Department of Gastrointestinal Surgery The Second Affiliated Hospital of Hainan Medical University Haikou Hainan Province China展开收起
PDF源文件 DOI 网页
125 天

4H‐CRCXL Mitigates RasV12‐Induced Phenotypes in Glioblastoma Model of Drosophila

作者
Pradeep Kumar; Vaishali Raghuvanshi; Prabhat Kumar; Rohit Kumar; Brijesh Singh Chauhan; Diksha Katiyar; Saripella Srikrishna展开收起
作者单位
1. Cancer and Neurobiology Laboratory, Department of Biochemistry, Institute of Science Banaras Hindu University Varanasi Uttar Pradesh India; 2. Department of Chemistry MMV, Banaras Hindu University Varanasi Uttar Pradesh India展开收起
PDF源文件 DOI 网页
350 天

Integrated Immunological Analysis of Interactions Between CXCL13+ T Cells and LAMP3+ DC in the Immunotherapy Response of Bladder Cancer

作者
Lin Zhou; Jinchao Zhu; Yushan Liu; Bin Xu展开收起
作者单位
1. Department of Urology Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China; 2. Department of Pathology Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。